Pharmaceutical company ProStrakan Group plc (LSE: PSK) climbed 4% after the company announced that it had received approval from the US Food and Drug Administration (‘FDA’) for Sancuso. Sancuso is a transdermal patch for the prevention of chemotherapy-induced nausea and vomiting.
The company said it expected to launch Sancuso in the US before the end of the year. The product will be marketed by a both ProStrakan and NovaQuest.
Dr Wilson Read the rest of this entry »

Healthy Diet Can’t Hurt, May Help Breast Cancer Patients

Researchers from Kaiser Permanente in Oakland and the University of Utah have reported that women with early-stage breast cancer might benefit from a healthy diet that includes foods such as fruits, vegetables, and whole grains, and minimizes refined foods and red meat. The details of this study appeared early online in the
on December 29, 2009.
Breast cancer is the second leading Read the rest of this entry »

ALL residents across western Sydney need to be concerned about health and problems affecting men.
Some health problems disproportionately affect men, such as 70per cent of all injury-related disease, 78per cent of suicide and 73per cent of road accidents.
Life expectancy for Australian men is 4.8 years less than women, and men under 75 are almost three times more likely to die from coronary heart disease, stroke and vascular disease than women; Read the rest of this entry »

“In issuing this midnight regulation, the Bush Administration has once again rejected medical and sound science in favor of misguided ideology that has no place in our government. The Administration has ignored the opposition of the American Medical Association, the American College of Obstetricians and Gynecologists, the American Hospital Association, Members of Congress, and hundreds of thousands of concerned citizens and practitioners who made Read the rest of this entry »

While the bear market in the third quarter hammered investment income for each of the state’s major health plans, all three insurers remain strong financially, according to their finance chiefs.
Analysts agreed, saying the companies are unlikely to be significantly hurt by the recent market turmoil. The drop in investment income is also not expected to force an increase in healthcare premiums, they said.
“Health plans’ enrollment is holding, their Read the rest of this entry »

Allergan Announces U.S. Food and Drug Administration (FDA) Approval
of LATISSE
IRVINE, Calif.–(
)–Allergan, Inc. (NYSE: AGN) today announced the U.S. Food and Drug
Administration (FDA) has approved LATISSE
(bimatoprost
ophthalmic solution) 0.03% as a novel treatment for hypotrichosis of the
eyelashes. Eyelash hypotrichosis is another name for having inadequate
or not enough eyelashes. LATISSE
is the first Read the rest of this entry »

Oh, so diet soda is better for you?
According to Gov. David Paterson’s proposed tax on classic soda, diet soda is good for you, and classic soda is not good for you. Recent studies, easily located online by entering “Diet Soda-Contents,” demonstrate that the opposite is true. More obese people drink diet soda than regular soda.
Compare the cans and check out the contents of diet soda vs. regular soda. The array of chemicals in diet soda are good Read the rest of this entry »

received $10 million to increase the capacity of its emergency room. United Medical Center, formerly
, received $11 million to build a pediatric emergency department. And the D.C. Primary Care Association was given $29.7 million to support four primary care facilities being developed in Wards 2, 4 and 8.
A decade ago, the District was awarded $245 million as part of the historic class-action settlement with the tobacco industry. More than $100 Read the rest of this entry »

An ugly side of the beauty business emerged today, as an
listed 930 reports of side effects for injectable wrinkle fillers such as Restylane and Juvederm.
The reports go back to 2003, and include swelling, allergic reactions and infections, among other problems. The briefing says there’s not a clear causal link between the products and the side effects, and doesn’t specify which products were involved.
But shares of Medicis, which Read the rest of this entry »

The U.S. Food and Drug Administration does little to oversee financial conflicts that doctors involved in clinical trials of drugs and medical devices may have, government investigators said Monday.
In 42 percent of trials, the FDA failed to receive disclosure forms from physicians and said that efforts to police such disclosures weren’t worth the effort,
reported. Results of the investigation, conducted by the U.S. Department of Health and Human Read the rest of this entry »